Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

High-risk HPV-16 DNA testing after treatment for carcinoma cervix.

Kashyap V, Hedau S.

Indian J Pathol Microbiol. 2012 Oct-Dec;55(4):594-5. doi: 10.4103/0377-4929.107842. No abstract available.

2.

Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.

Alhamany Z, El Mzibri M, Kharbach A, Malihy A, Abouqal R, Jaddi H, Benomar A, Attaleb M, Lamalmi N, Cherradi N.

J Infect Dev Ctries. 2010 Nov 24;4(11):732-9.

3.

Human papillomavirus prevalence in women who have and have not undergone hysterectomies.

Castle PE, Schiffman M, Glass AG, Rush BB, Scott DR, Wacholder S, Dunn A, Burk RD.

J Infect Dis. 2006 Dec 15;194(12):1702-5. Epub 2006 Nov 3.

PMID:
17109342
4.

Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study.

Zhang D, Zhang Q, Zhou L, Huo L, Zhang Y, Shen Z, Zhu Y.

BMC Cancer. 2010 Nov 26;10:650. doi: 10.1186/1471-2407-10-650.

5.

Comparison between the Abbott RealTime High Risk HPV assay and the Hybrid Capture 2 assay for detecting high-risk human papillomavirus DNA in cervical specimens.

Kaliterna V, Lepej SZ, Vince A.

J Med Microbiol. 2009 Dec;58(Pt 12):1662-3. doi: 10.1099/jmm.0.012138-0. Epub 2009 Aug 6. No abstract available.

PMID:
19661205
6.

Longitudinal study of patients after surgical treatment for cervical lesions: detection of HPV DNA and prevalence of HPV-specific antibodies.

Tachezy R, Mikysková I, Ludvíková V, Rob L, Kucera T, Slavík V, Beková A, Robová H, Pluta M, Hamsíková E.

Eur J Clin Microbiol Infect Dis. 2006 Aug;25(8):492-500.

PMID:
16896828
8.

Human papillomavirus prevalence in women with normal cytology and with cervical cancer in Natal, Brazil.

Fernandes JV, Meissner Rde V, Carvalho MG, Fernandes TA, Azevedo PR, de Azevedo JW, de Araújo JM.

Mol Med Rep. 2011 Nov-Dec;4(6):1321-6. doi: 10.3892/mmr.2011.579. Epub 2011 Sep 1.

PMID:
21887467
9.

Region-wise distribution of high-risk human papillomavirus types in squamous cell carcinomas of the cervix in India.

Pillai RM, Babu JM, Jissa VT, Lakshmi S, Chiplunkar SV, Patkar M, Tongaonkar H, Reddy KB, Chakka KN, Siddiqui M, Roychoudury S, Abraham P, Peedicayil A, Gnanamony M, Subashini J, Ram TS, Dey B, Singh N, Singh A, Jain SK, Jayshree RS.

Int J Gynecol Cancer. 2010 Aug;20(6):1046-51. doi: 10.1111/IGC.0b013e3181e02fe0.

PMID:
20683415
10.

Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.

Gupta S, Sodhani P, Sharma A, Sharma JK, Halder K, Charchra KL, Sardana S, Singh V, Sehgal A, Das BC.

Cytopathology. 2009 Aug;20(4):249-55. doi: 10.1111/j.1365-2303.2008.00611.x. Epub 2008 Oct 24.

PMID:
19018810
11.

Prevaccination distribution of human papillomavirus types in Italian women with high-risk lesions and cervical neoplasia.

De Francesco MA, Gargiulo F, Schreiber C, Ciravolo G, Salinaro F, Manca N.

Intervirology. 2010;53(6):417-25. doi: 10.1159/000317292. Epub 2010 Jul 2.

PMID:
20606464
12.

HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ.

Cricca M, Venturoli S, Morselli-Labate AM, Costa S, Santini D, Ambretti S, Musiani M, Zerbini M.

J Med Virol. 2006 Apr;78(4):494-500.

PMID:
16482538
13.

Performance of the Abbott RealTime high-risk HPV test in women with abnormal cervical cytology smears.

Cuzick J, Ambroisine L, Cadman L, Austin J, Ho L, Terry G, Liddle S, Dina R, McCarthy J, Buckley H, Bergeron C, Soutter WP, Lyons D, Szarewski A.

J Med Virol. 2010 Jul;82(7):1186-91. doi: 10.1002/jmv.21801.

PMID:
20513082
14.

High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study.

Stoler MH, Wright TC Jr, Sharma A, Apple R, Gutekunst K, Wright TL; ATHENA (Addressing THE Need for Advanced HPV Diagnostics) HPV Study Group.

Am J Clin Pathol. 2011 Mar;135(3):468-75. doi: 10.1309/AJCPZ5JY6FCVNMOT.

PMID:
21350104
15.

[Enhanced molecular techniques for the diagnosis of human papillomavirus infections].

Ursu RG, Onofriescu M, Nemescu D, Iancu LS.

Rev Med Chir Soc Med Nat Iasi. 2009 Oct-Dec;113(4):1205-10. Romanian.

PMID:
20191900
16.

Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples.

Munoz M, Camargo M, Soto-De Leon SC, Sanchez R, Parra D, Pineda AC, Sussmann O, Perez-Prados A, Patarroyo ME, Patarroyo MA.

PLoS One. 2013;8(2):e56509. doi: 10.1371/journal.pone.0056509. Epub 2013 Feb 13.

17.

Prevalence and risk factors for human papillomavirus DNA in cervical cytology.

Kasap B, Yetimalar H, Keklik A, Yildiz A, Cukurova K, Soylu F.

Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):168-71. doi: 10.1016/j.ejogrb.2011.06.021. Epub 2011 Jul 18.

PMID:
21764503
18.

Analytical performance of Cervista HPV 16/18 genotyping test for cervical cytology samples.

Bartholomew DA, Luff RD, Quigley NB, Curtis M, Olson MC.

J Clin Virol. 2011 May;51(1):38-43. doi: 10.1016/j.jcv.2011.01.016. Epub 2011 Mar 4.

PMID:
21376660
19.

Hospital-based prevalence and sensitivity of high-risk human papillomavirus in Thai urban population.

Suwannarurk K, Tapanadechopol P, Pattaraarchachai J, Bhamarapravati S.

Cancer Epidemiol. 2009 Jul;33(1):56-60. doi: 10.1016/j.canep.2009.04.006. Epub 2009 Jun 26.

PMID:
19679049
20.

Human papillomavirus genotypes associated with cervical neoplasia in India.

Peedicayil A, Abraham P, Sathish N, John S, Shah K, Sridharan G, Gravitt P.

Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1591-5.

PMID:
16884371

Supplemental Content

Support Center